Brain-eating amoebas are hard to treat and nearly always fatal. But researchers have isolated a compound that could help stop ...
Missouri AG told Lilly to stop forcing hospitals to provide claims data to receive discounted medicines under 340B, a sign ...
WASHINGTON – The Food and Drug Administration published draft guidance on Tuesday that would streamline approvals of some ...
My colleague Chelsea Cirruzzo wrote last month that the Iowa gubernatorial race would be the biggest test of Kennedy’s ...
Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one ...
A U.S. judge rejected a bid to block Eli Lilly from running what Novo Nordisk claims is a “deceptive” advertising campaign ...
Employers have mostly protected their workers from the sky-high premium spikes they’d otherwise see as health care costs ...
Bon Secours Mercy Health could soon become one of the country’s biggest ambulatory surgery center operators, a move that’s ...
One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung ...
Moderna's CEO Stéphane Bancel on what's next after the recent success in cancer vaccine, and how that impacts the company's ...
Kennedy Jr. and other top federal health officials announced a new National Institutes of Health center that would ...
A Phase 3 trial of a targeted drug developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results